
UNH
UnitedHealth Group Incorporated · NYSE
$512.60+0.97%
9 Sep close- Market cap
- $472B
- Sector
- Health care
Income statement
Revenue, costs and earnings
Loading

| Quarter | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | TTM | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | 30 Sep 21 | 31 Dec 21 | 31 Mar 22 | 30 Jun 22 | 30 Sep 22 | 31 Dec 22 | 31 Mar 23 | 30 Jun 23 | 30 Sep 23 | 31 Dec 23 | 31 Mar 24 | 30 Jun 24 | 30 Sep 24 | 31 Dec 24 | 31 Mar 25 | 30 Jun 25 | 30 Sep 25 | 31 Dec 25 | 31 Mar 26 | 30 Jun 26 | 30 Jun 26 | Each line by period |
| Revenue | $71.9B | $76.2B | $77.4B | $79.8B | $81.0B | $85.9B | $88.7B | $91.5B | $92.9B | $98.5B | $95.6B | $98.6B | $100.1B | $106.1B | $102.3B | $105.5B | $107.1B | $113.5B | $109.3B | $112.8B | $442.8B | |
| Cost of revenue | −$54.6B | −$57.8B | −$59.0B | −$60.9B | −$61.8B | −$65.5B | −$68.0B | −$70.1B | −$71.2B | −$75.5B | −$73.6B | −$75.9B | −$77.1B | −$81.7B | −$79.2B | −$81.7B | −$82.9B | −$87.9B | −$85.5B | −$88.2B | −$344.5B | |
| Gross profit | $17.3B | $18.4B | $18.4B | $18.9B | $19.2B | $20.4B | $20.7B | $21.4B | $21.7B | $23.0B | $21.9B | $22.6B | $23.0B | $24.4B | $23.1B | $23.8B | $24.2B | $25.6B | $23.9B | $24.6B | $98.3B | |
| Operating costs | −$7.4B | −$7.8B | −$7.9B | −$8.1B | −$8.2B | −$8.8B | −$9.0B | −$9.3B | −$9.4B | −$10.0B | −$9.5B | −$9.8B | −$10.0B | −$10.6B | −$10.2B | −$10.5B | −$10.7B | −$11.3B | −$9.9B | −$10.2B | −$42.1B | |
| Cost of products sold | −$3.1B | −$3.3B | −$3.3B | −$3.4B | −$3.5B | −$3.7B | −$3.8B | −$3.9B | −$4.0B | −$4.2B | −$4.0B | −$4.1B | −$4.2B | −$4.4B | −$4.3B | −$4.4B | −$4.5B | −$4.7B | −$4.2B | −$4.3B | −$17.6B | |
| Depreciation and amortisation | −$1.4B | −$1.5B | −$1.5B | −$1.6B | −$1.6B | −$1.7B | −$1.8B | −$1.8B | −$1.8B | −$1.9B | −$1.8B | −$1.9B | −$1.9B | −$2.0B | −$2.0B | −$2.0B | −$2.1B | −$2.2B | −$1.9B | −$2.0B | −$8.1B | |
| Restructuring and other charges | −$0.1B | −$0.1B | −$0.4B | −$0.4B | −$0.4B | −$0.4B | −$0.5B | −$0.5B | −$0.5B | −$0.6B | −$0.7B | −$0.7B | −$0.7B | −$0.8B | −$0.4B | −$0.4B | −$0.4B | −$0.4B | −$1.1B | −$1.1B | −$3.0B | |
| Operating income | $5.4B | $5.7B | $5.3B | $5.5B | $5.5B | $5.9B | $5.7B | $5.9B | $6.0B | $6.3B | $5.9B | $6.1B | $6.2B | $6.5B | $6.3B | $6.5B | $6.6B | $7.0B | $6.8B | $7.1B | $27.4B | |
| Operating margin | 7.5% | 7.5% | 6.8% | 6.8% | 6.8% | 6.8% | 6.4% | 6.4% | 6.4% | 6.4% | 6.2% | 6.2% | 6.2% | 6.2% | 6.1% | 6.1% | 6.1% | 6.1% | 6.3% | 6.3% | 6.2% | |
| Other income and expense, net | −$0.2B | −$0.2B | −$0.2B | −$0.2B | −$0.2B | −$0.2B | −$0.3B | −$0.3B | −$0.3B | −$0.3B | −$0.3B | −$0.3B | −$0.3B | −$0.3B | −$0.4B | −$0.4B | −$0.4B | −$0.4B | −$0.5B | −$0.5B | −$1.8B | |
| Income before taxes | $5.2B | $5.5B | $5.1B | $5.3B | $5.3B | $5.6B | $5.4B | $5.6B | $5.7B | $6.0B | $5.6B | $5.8B | $5.8B | $6.2B | $5.9B | $6.1B | $6.2B | $6.5B | $6.4B | $6.6B | $25.7B | |
| Income tax expense | −$1.2B | −$1.3B | −$1.1B | −$1.2B | −$1.2B | −$1.3B | −$1.2B | −$1.3B | −$1.3B | −$1.4B | −$1.3B | −$1.3B | −$1.3B | −$1.4B | −$1.4B | −$1.4B | −$1.4B | −$1.5B | −$1.5B | −$1.5B | −$5.9B | |
| Net income | $4.0B | $4.3B | $3.9B | $4.1B | $4.1B | $4.4B | $4.2B | $4.3B | $4.4B | $4.6B | $4.3B | $4.4B | $4.5B | $4.8B | $4.5B | $4.7B | $4.8B | $5.0B | $4.9B | $5.0B | $19.8B | |
| Diluted shares, billions | 0.95 | 0.95 | 0.95 | 0.95 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.92 | 0.92 | 0.92 | |
| Diluted earnings per share | $4.24 | $4.48 | $4.15 | $4.27 | $4.39 | $4.62 | $4.45 | $4.60 | $4.66 | $4.94 | $4.59 | $4.72 | $4.86 | $5.12 | $4.89 | $5.04 | $5.13 | $5.44 | $5.34 | $5.49 | $21.49 | |
| Derived metrics | ||||||||||||||||||||||
| Revenue growth, period on period | no prior period | +6.0% | +1.5% | +3.1% | +1.5% | +6.0% | +3.3% | +3.1% | +1.5% | +6.0% | −2.9% | +3.1% | +1.5% | +6.0% | −3.6% | +3.1% | +1.5% | +6.0% | −3.7% | +3.1% | not comparable | |
| Gross margin | 24.1% | 24.1% | 23.7% | 23.7% | 23.7% | 23.7% | 23.4% | 23.4% | 23.3% | 23.3% | 23.0% | 23.0% | 23.0% | 23.0% | 22.6% | 22.6% | 22.6% | 22.6% | 21.8% | 21.8% | 22.2% | |
| Net margin | 5.6% | 5.6% | 5.1% | 5.1% | 5.1% | 5.1% | 4.7% | 4.7% | 4.7% | 4.7% | 4.5% | 4.5% | 4.5% | 4.5% | 4.4% | 4.4% | 4.5% | 4.4% | 4.5% | 4.5% | 4.5% | |
Billions of dollars, except earnings per share in dollars and the share count in billions. Growth is on the period before; the trailing twelve months is on the last full period.